Community Acquired Pneumonia Dora E. Wiskirchen‚ PharmD‚ BCPS PHCY 836 – Day 5 PM Learning Objectives Identify risk factors for the development of pneumonia. Explain the pathophysiology‚ signs and symptoms‚ most common bacterial etiologies and associated resistance patterns‚ severity of illness scoring systems‚ and diagnostic techniques for pneumonia. Define atypical pneumonia and characterize patients who may be at risk for developing this type of pneumonia. Evaluate pharmacologic
Premium Pneumonia
dysfunction. 2. Describe effects of aging on the respiratory system. 3. Identify significant assessment data that should be obtained from a patient. 4. Describe pH and the mechanisms that regulate acid-base balance. 5. Describe the common causes‚ pathophysiology‚ compensatory mechanisms‚ and clinical manifestations of respiratory and metabolic acidosis and alkalosis. 6. Interpret arterial blood gas results. 7. Identify the signs and symptoms of inadequate oxygenation and the implications of these findings
Premium Pulmonology Arterial blood gas
Main image ©Muratseyit/istockphoto Pathogenesis and diagnosis of bronchiectasis Educational aims To describe the important factors involved in the pathogenesis of bronchiectasis. To define how a diagnosis of bronchiectasis is made. P.T. King1 E. Daviskas2 1 Dept of Respiratory and Sleep Medicine/Dept of Medicine‚ Monash Medical Centre‚ Melbourne‚ and 2Dept of Respiratory and Sleep Medicine‚ Royal Prince Alfred Hospital‚ Sydney‚ Australia. Summary Bronchiectasis is an important
Premium Asthma Bronchiectasis Chronic obstructive pulmonary disease
disease‚ COPD‚ is a trending disease that is a common lung disease. Smoking is the leading cause of COPD but being a smoker does not mean that you will get COPD. Chronic bronchitis‚ emphysema‚ and asthma are obstructive diseases that impair breathing and cause symptoms related to COPD. After reviewing The RoSPA Occupational Safety & Health Journal there is an understanding of the regulations regarding employer’s responsibilities towards people that are still working and suffering with COPD. Employees
Premium Asthma Chronic obstructive pulmonary disease Pneumonia
Chronic obstructive pulmonary disease (COPD) is one of the most common chronic inflammatory lung diseases in the world. It has been suggested that COPD cases represent 95% among all cases of chronic lower lung diseases. COPD is usually represented as several lung diseases including emphysema‚ chronic bronchitis‚ and refractory asthma. Since COPD is a chronic disease‚ it may have an effect on patients especially on their health related quality of life (HRQoL). HRQoL is defined as the discernments
Premium Health care Medicine Health care provider
Comorbidities Systemic manifestations and Comorbidities of COPD It defines Comorbidities’ existence of each disease entity separate addition‚ during the clinical course of a disease object office [1]. The presence of Comorbidities has prognostic value with respect to survival‚ but also compared with the functional state. As with other chronic diseases‚ the prevalence of Comorbidities in elderly COPD is extremely high‚ the severity of Comorbidities and their impact on the various health status of
Premium Smoking Tobacco smoking Cancer
fact many practice guidelines advise against this‚ or counter-indicate BBs with COPD‚ for fear of the antagonistic actions of BBs will counteract the beta agonist actions of the patient’s COPD medication resulting in bronchospasms and other adverse effects. There has been a lot of controversial evidence about this topic‚ however‚ recent emerging studies have shown the BBs CVD benefits outweigh the risks associated with COPD. A compilation of retrospective studies show the benefits of beta blockade in
Premium Myocardial infarction Heart
References: Porth‚ C. M. (2004). Disorders of ventilation and gas exchange. Pathophysiology concepts of altered health states‚ seventh edition (pp. 691-693). Philadelphia: Lippincott Williams and Wilkins. Merck Manual. Pneumothorax. The Merck Manual second home edition‚ Chapter 52. Retrieved April 18th‚2005 from http://www.merck.com/mmhe/sec04/ch052d
Premium Pneumothorax Pulmonology
In review article of self-management education in asthma and COPD known as chronic obstructive pulmonary disease. A professor of respiratory medicine and educator provide research on 5 European countries ask individuals how many times they visits their general practitioner for review of asthma or COPD. In the discussions 83% of the patients were reported to see their general practitioner that left the patients who has asthma or copd on their own for forty-nine minutes. In the article‚ Professor
Premium Asthma Chronic obstructive pulmonary disease Lung
Paul Ross PAS-3 Professor Irving PAS 665 Emphysema - Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is a common respiratory condition characterized by airflow limitation currently affecting more than 5% of the population and is associated with high morbidity and mortality. In the US COPD is ranked 3rd in cause of death responsible for killing more than 120‚000 individuals per year. The National Health Interview Survey reports the prevalence of emphysema
Premium Chronic obstructive pulmonary disease Asthma